• Treffer 26 von 46
Zurück zur Trefferliste

Pre-analytical challenges for the quantification of endocannabinoids in human serum

  • Endocannabinoids (ECs) are potent lipid mediators with high physiological relevance. They are involved in a wide variety of diseases like depression or multiple sclerosis and are closely connected to metabolic parameters in humans. Therefore, their suitability as a biomarker in different (patho-)physiological conditions is discussed intensively and predominantly investigated by analyzing systemic concentrations in easily accessible matrices like blood. Carefully designed pre-analytical sample handling is of major importance for high-quality data, but harmonization is not achieved yet. Whole blood is either processed to serum or plasma before the onset of analytical workflows and while knowledge about pre-analytical challenges in plasma handling is thorough they were not systematically investigated for serum. Therefore, the ECs AEA and 2-AG, and closely related EC-like substances 1-AG, DHEA, and PEA were examined by LC-MS/MS in serum samples of nine healthy volunteers employing different pre-analytical sample handling protocols, including prolonged coagulation, and storage after centrifugation at room temperature (RT) or on ice. Furthermore, all analytes were also assessed in plasma samples obtained from the same individuals at the same time points to investigate the comparability between those two blood-based matrices regarding obtained concentrations and their 2-AG/1-AG ratio. This study shows that ECs and EC-like substances in serum samples were significantly higher than in plasma and are especially prone to ex vivo changes during initial and prolonged storage for coagulation at RT. Storage on ice after centrifugation is less critical. However, storage at RT further increases 1-AG and 2-AG concentrations, while also lowering the already reduced 2-AG/1-AG ratio due to isomerization. Thus, avoidance of prolonged processing at RT can increase data quality if serum as the matrix of choice is unavoidable. However, serum preparation in itself is expected to initiate changes of physiological concentrations as standard precautionary measures like fast and cooled processing can only be utilized by using plasma, which should be the preferred matrix for analyses of ECs and EC-like substances.

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar
Metadaten
Verfasserangaben:Daniel KratzORCiD, Alena Sens, Stephan Martin Gastón Helmut Johannes SchäferGND, Lisa Katharina HahnefeldORCiDGND, Gerd GeisslingerORCiDGND, Dominique Jeanette ThomasORCiDGND, Robert GurkeORCiDGND
URN:urn:nbn:de:hebis:30:3-783409
DOI:https://doi.org/10.1016/j.jchromb.2022.123102
ISSN:1570-0232
Titel des übergeordneten Werkes (Englisch):Journal of Chromatography B
Verlag:Elsevier
Verlagsort:Amsterdam
Dokumentart:Wissenschaftlicher Artikel
Sprache:Englisch
Datum der Veröffentlichung (online):10.01.2022
Datum der Erstveröffentlichung:07.01.2022
Veröffentlichende Institution:Universitätsbibliothek Johann Christian Senckenberg
Datum der Freischaltung:02.11.2023
Freies Schlagwort / Tag:Blood sample handling; Endocannabinoids; Plasma; Pre-analytics; Serum
Jahrgang:1190
Ausgabe / Heft:123102
Aufsatznummer:123102
Seitenzahl:8
HeBIS-PPN:515065056
Institute:Medizin
Fachübergreifende Einrichtungen / Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit
DDC-Klassifikation:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Lizenz (Deutsch):License LogoCreative Commons - CC BY - Namensnennung 4.0 International